Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

A Single Bout of Exercise Enhances the Efficacy of Rituximab Against Autologous Chronic Lymphocytic Leukaemia B Cells Ex Vivo By Transiently Increasing Natural Killer Cell Frequency in Blood, and Simultaneously Mobilises CD5 + CD19 + CD20 + B Cells into Blood

Harrison D Collier-Bain, Annabelle Emery, Adam J Causer, Frankie F Brown, Rebecca Oliver, David Dutton, Josephine Crowe, Daniel Augustine, John Graby, Shoji Leach, Rachel Eddy, Daniela Rothschild Rodriguez, Juliet C Gray, Mark S Cragg, Kirstie L Cleary, Sally Moore, James Murray, James E Turner, John P Campbell

Blood (2023) 142 (Supplement 1): 1179.

https://doi.org/10.1182/blood-2023-190009

Published: 2023

Journal Articles

Safety and Feasibility of a 16-Week Progressive Exercise Intervention in Treatment Naïve Chronic Lymphocytic Leukaemia

Frankie F Brown, Rebecca Oliver, Adam J Causer, Harrison D Collier-Bain, Annabelle Emery, Rachel Eddy, David Dutton, Josephine Crowe, Daniel Augustine, John Graby, Dan Rees, Daniela Rothschild Rodriguez, Oliver Peacock, Sally Moore, James Murray, James E Turner, John P Campbell

Blood (2023) 142 (Supplement 1): 6533.

https://doi.org/10.1182/blood-2023-186956

Published: 2023

Journal Articles

Prenatal Allospecific Tolerance Is Characterized By Early T reg Expansion and a Surprisingly Slow Pace for T eff Clonal Deletion

Beverly SI Strong, PhD, Amanda E Lee, MD, Tess J Newkold, Lucas E Turner, Aimen F Shaaban, MD

Blood (2015) 126 (23): 3070.

https://doi.org/10.1182/blood.V126.23.3070.3070

Published: 2015

Journal Articles

Asymmetric Allospecific Signals Shape iNKT Cell Lineage Fate Decisions

Beverly SI Strong, PhD, Tess J Newkold, Amanda E Lee, MD, Lucas E Turner, Jonathon W Heusel, MD PhD, Aimen F Shaaban, MD

Blood (2015) 126 (23): 4274.

https://doi.org/10.1182/blood.V126.23.4274.4274

Published: 2015

Journal Articles

Stem Cell-like Characteristics of MM Plasma Cells Vary By ROS Levels: Implications for Targeted Therapy

Priyangi A Malaviarachchi, BS, Donald E Turner, BS, Caleb K. Stein, MS, Bart Barlogie, MD PhD, Gareth J Morgan, MDPhD, Joshua Epstein, DSc, Shmuel Yaccoby, PhD, Sarah K. Johnson, PhD

Blood (2015) 126 (23): 1820.

https://doi.org/10.1182/blood.V126.23.1820.1820

Published: 2015

Journal Articles

Self-Engagement Of An NKT Cell Inhibitory Receptor During Development Alters Receptor Expression and Cellular Function

Beverly S Strong, PhD, Tess Rotzler, Ram Wadhwani, Lucas E Turner, Emily Midura, MD, Aimen Shaaban, MD

Blood (2013) 122 (21): 4480.

https://doi.org/10.1182/blood.V122.21.4480.4480

Published: 2013

Journal Articles

A Retrospective Study of Alemtuzumab Level, T Cell Chimerism and Graft Versus Host Disease Using Intermediate Dose Alemtuzumab for Matched Related and Matched Unrelated Reduced Intensity Transplantation.

Andrew Charlton, MD, Laura Spence, MD, Venetia Bigley, MD, Natasha Groves, PhD, Geoff Hale, PhD, Sarah Pagan, BSc, Brie E Turner, PhD, Gail Jones, MD, PhD, Graham H Jackson, MD, PhD, Anne M Dickinson, PhD, Matthew Collin, MD, PhD

Blood (2009) 114 (22): 3333.

https://doi.org/10.1182/blood.V114.22.3333.3333

Published: 2009

Journal Articles

Delayed Onset GVHD Following Reduced Intensity Conditioning HSCT Is Associated with Persisting Host DC and Late Emergence of Activated Donor DC.

Brie E. Turner, BSc (Hons), Melinda E. Kambouris, BSc(Hons), Janusz Lange, MD, Kerry Atkinson, MBBS, MD, Derek N. Hart, MBBS, DPhil, David J. Munster, PhD, Alison M. Rice, PhD

Blood (2006) 108 (11): 3218.

https://doi.org/10.1182/blood.V108.11.3218.3218

Published: 2006

Journal Articles

Conditioning Intensity and Dendritic Cell (DC) Activation: Implications for GVHD Control Using DC Depleting Antibodies.

Brie E. Turner, BSc (Hons), Melinda Christensen, B.Sc, Janusz Lange, MBBS, Ann-Marie Burns, Derek N.J. Hart, MBBS, D. Phil, Kerry Atkinson, MBBS, MD, David J. Munster, PhD, Alison M. Rice, PhD

Blood (2005) 106 (11): 3112.

https://doi.org/10.1182/blood.V106.11.3112.3112

Published: 2005

Journal Articles

The effect of alpha-thalassemia on the expression of the beta- thalassemia/HPFH heterozygote in a black family

E Beutler, E Turner, W Kuhl

Blood (1981) 57 (6): 1132–1134.

https://doi.org/10.1182/blood.V57.6.1132.1132

Published: 1981

NARROW

A Single Bout of Exercise Enhances the Efficacy of Rituximab Against Autologous Chronic Lymphocytic Leukaemia B Cells Ex Vivo By Transiently Increasing Natural Killer Cell Frequency in Blood, and Simultaneously Mobilises CD5 + CD19 + CD20 + B Cells into Blood

Safety and Feasibility of a 16-Week Progressive Exercise Intervention in Treatment Naïve Chronic Lymphocytic Leukaemia

Prenatal Allospecific Tolerance Is Characterized By Early T reg Expansion and a Surprisingly Slow Pace for T eff Clonal Deletion

Asymmetric Allospecific Signals Shape iNKT Cell Lineage Fate Decisions

Stem Cell-like Characteristics of MM Plasma Cells Vary By ROS Levels: Implications for Targeted Therapy

Self-Engagement Of An NKT Cell Inhibitory Receptor During Development Alters Receptor Expression and Cellular Function

A Retrospective Study of Alemtuzumab Level, T Cell Chimerism and Graft Versus Host Disease Using Intermediate Dose Alemtuzumab for Matched Related and Matched Unrelated Reduced Intensity Transplantation.

Delayed Onset GVHD Following Reduced Intensity Conditioning HSCT Is Associated with Persisting Host DC and Late Emergence of Activated Donor DC.

Conditioning Intensity and Dendritic Cell (DC) Activation: Implications for GVHD Control Using DC Depleting Antibodies.

The effect of alpha-thalassemia on the expression of the beta- thalassemia/HPFH heterozygote in a black family

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only